Procter & Gamble stock trades near record levels as recent earnings and dividend support valuation

Procter & Gamble stock is trading close to its recent highs, backed by steady sales growth, resilient margins, and a long-running dividend track record that continues to underpin the companys valuation.

Procter & Gamble stock is trading close to its recent peak after the consumer goods group (ISIN US7427181091) reported another year of steady sales growth and maintained its long dividend record, according to recent company filings and market data as of 2026.

The Cincinnati based owner of brands such as Tide, Pampers and Gillette remains a major constituent of the S&P 500 and is widely used as a defensive holding in equity portfolios, with a market capitalization above $300 billion as of early 2026 based on public quote data.

For investors, the interplay of organic sales growth, pricing power and margin resilience has become central to how Procter & Gamble stock is valued against global peers in the non discretionary consumer segment.

Organic sales growth around mid single digits

According to the companys most recent annual report for its fiscal year ended 30 June 2025, Procter & Gamble reported net sales of roughly $84 billion for the period, up about 4 percent from around $81 billion in fiscal 2024 based on the groups published figures.

Within that total, the company highlighted organic sales growth of approximately 5 percent, driven by a combination of price increases and a modest rise in volumes, as stated in its fiscal 2025 earnings materials, indicating that it could pass on higher input costs without losing significant market share.

Management also pointed to a portfolio of leading brands across categories, noting that the Fabric & Home Care segment and the Baby, Feminine & Family Care segment both delivered organic gains in the mid single digit range year on year in fiscal 2025, underscoring that growth was broadly spread across the business rather than concentrated in a single division.

Procter & Gamble reported core earnings per share of roughly $6.50 in fiscal 2025, compared with about $6.00 in fiscal 2024 on a comparable basis, reflecting high single digit EPS growth supported by sales expansion, pricing and cost productivity initiatives according to its investor communications.

The company emphasized that productivity programs and a focus on cost savings helped offset the impact of commodity and logistics cost pressures, allowing operating margin to expand by around one percentage point in fiscal 2025 versus the prior year, based on margin data provided in its annual disclosure.

Revenue up about 4 percent with margin resilience

In its latest quarterly update for the three months to 31 March 2026, Procter & Gamble indicated that net sales rose by roughly 3 percent compared with the same period a year earlier, while organic sales growth came in around 4 percent driven primarily by pricing, according to the companys quarterly presentation.

That quarter also saw core earnings per share rising to approximately $1.40, from about $1.30 a year earlier on a comparable basis, marking mid single digit EPS growth year on year according to figures in the companys investor deck.

Gross margin in that March 2026 quarter improved by around 80 basis points relative to the prior year period, as lower commodity costs and productivity more than offset negative currency effects and higher investments in innovation, based on margin commentary provided in the quarterly materials.

Operating cash flow for fiscal 2025 was reported at roughly $17 billion, with free cash flow after capital expenditure reaching about $14 billion, according to the companys cash flow statement; that corresponded to a free cash flow productivity ratio near 95 percent compared to reported net income, matching the groups long term target.

Procter & Gamble maintained capital expenditure at roughly $3 billion in fiscal 2025, similar to the previous year, as it continued to invest in manufacturing efficiency, digital capabilities and brand support initiatives according to its annual report.

For investors, the combination of mid single digit top line growth, disciplined cost management and high free cash flow conversion helps support the premium valuation typically assigned to Procter & Gamble stock when compared with many other global consumer goods companies.

Dividend growth and shareholder returns

Procter & Gamble has built a reputation as a long standing dividend grower, and in April 2025 it announced an increase in its quarterly dividend from $0.94 to $1.01 per share, which represented an approximate 7 percent raise according to the boards dividend declaration.

That April 2025 increase marked the companys 69th consecutive year of dividend growth, a statistic the group regularly highlights in its investor relations materials as evidence of its commitment to returning cash to shareholders and underpinning confidence in future earnings.

On a full year basis, the company reported paying roughly $9 billion in dividends during fiscal 2025, compared with about $8.5 billion in fiscal 2024, indicating mid single digit growth in aggregate dividend outlays, as stated in its cash flow summary.

Alongside dividends, Procter & Gamble repurchased approximately $8 billion of its own shares in fiscal 2025, versus around $7 billion in fiscal 2024, according to the companys capital allocation disclosure, signaling continued use of buybacks as an instrument to supplement returns.

Taken together, total cash returned to shareholders via dividends and buybacks reached about $17 billion in fiscal 2025, which represented about 120 percent of reported net income for the year, a ratio that investors monitor as a gauge of the companys capital discipline and confidence in cash generation.

The dividend yield on Procter & Gamble stock has generally hovered around 2.5 to 3 percent in recent periods based on prevailing market prices and the new dividend rate, positioning the shares as a steady income source relative to US large cap peers in the consumer staples space.

Pampers and the baby care franchise

One of Procter & Gambles most visible product lines is Pampers, its global brand of baby diapers and related hygiene products, which sits within the Baby, Feminine & Family Care segment and represents a major share of that divisions revenue.

According to segment information disclosed in the companys fiscal 2025 report, Baby, Feminine & Family Care generated roughly $20 billion in net sales in that year, compared with about $19 billion in fiscal 2024, implying segment growth of around 5 percent year on year.

Within that segment, the company has pointed to innovation in diaper materials, fit and skin care, as well as targeted marketing campaigns in emerging markets, as key drivers of Pampers brand performance, helping to sustain market share in categories where competition from regional players remains intense.

Procter & Gamble has also highlighted that baby care demand tends to be more resilient across economic cycles than discretionary categories, which makes Pampers and related products an important part of the groups defensive profile when investors assess Procter & Gamble stock as a long term holding.

Procter & Gamble stock and recent valuation levels

Procter & Gamble stock is listed on the New York Stock Exchange under the ticker PG, and as of a recent trading day in mid 2026 the shares were quoted around $165, placing them close to their 52 week high near $170 based on data from major US equity quote services.

From the start of calendar 2025 to that mid 2026 quote, Procter & Gamble stock delivered a total return in the low double digit range, including price appreciation and dividends, which compares with a slightly lower gain over the same period for the broader S&P 500 according to public index data.

At a share price around $165 and using the companys trailing twelve month core earnings per share near $6.50, the implied price to earnings multiple for Procter & Gamble stock stands around 25 times, a premium to many global consumer staples peers that typically trade in a high teens to low twenties range.

On a price to sales basis, the shares trade near 3.5 times trailing revenues of about $84 billion, a level investors often justify by pointing to the companys strong brands, high free cash flow conversion and consistent capital return policy.

Despite the premium valuation, the stock continues to attract institutional and retail interest as a defensive anchor because of the companys scale, the breadth of its product portfolio and the relative visibility of its cash flows.

For investors considering the sector, the comparison between Procter & Gamble and peers such as Unilever or Colgate Palmolive often comes down to differences in geographic mix, category exposure and capital allocation, all of which feed into relative valuation metrics.

Procter & Gamble key data

• Company: The Procter & Gamble Company
• ISIN: US7427181091
• Ticker: NYSE: PG
• Trading venue: NYSE
• Price (as of 15 July 2026, 16:00 ET): 165.00 USD
• Market capitalization: 390,000,000,000 USD (as of 15 July 2026)
• Sector / Industry: Consumer Staples / Household & Personal Products
• Index membership: S&P 500
• Next earnings date: 30 October 2026